Talking About Men's Healthâ„¢

The American Fertility Association (The AFA) and Men’s Health Network (MHN) have joined forces to disseminate monthly articles about Male Reproductive Health. As you’ll read in the introduction from Dr. Ajay Nangia and Dr. Stanton Honig, below, the articles are being generated from a collaborative organization called MRHA – the Male Reproductive Health Alliance, of which The AFA and MHN are founding members.

Continue Reading

Advances in treatment and continued vigilance in early cancer screening are creating real progress and saving lives. Talking about Men’s Health contributor Dr. Samadi reports for Fox News:

Continue Reading

Watch the video below to learn about minimally invasive prostate cancer and other cancer surgery. Dr. Samadi explains the benefits over traditional prostate cancer surgery.

By: Michael J Rovito, Ph.D and Janna Manjelievskaia

The focus of prostate cancer prevention research has switched FROM advocating for screening TO advocating for informed decision-making among men. In other words, we are now trying to inform men of their options and advocate that they have an open and honest dialogue with their physician on their treatment options. Joseph-Williams et al (2010) looks at the relationship between informed decision making and usage of decision aids. Decision aids, which are often web or computer based, are being used more often in intervention research as they play a key role in patient participation. However, not enough research has been done to test the effectiveness of these aids or how to develop the best methods for implementation. In other words, we need to know ‘WHY’ these aides work so well more so than anything. But we are getting ahead of ourselves… Continue Reading

Yesterday, the Medicare Evidence Development and Coverage Advisory Committee’s (MEDCAC) vote on a number of questions amounted to a recommendation to the Centers for Medicare and Medicaid Services (CMS) to cover Provenge, a therapeutic vaccine for men with advanced prostate cancer.  While the recommendation was not overwhelmingly enthusiastic, Provenge clears one hurdle on its way to Medicare coverage.  CMS is expected to make its final recommendation in the next few months.  This is a small victory for the estimated 100,000 men who have advanced prostate cancer and the process has not been without controversy. Continue Reading

That battle against prostate cancer is fought on many fronts:  Patients, their families and medical providers actively fight the disease, researchers toil to find the right combination of molecules or technology to find, treat and prevent the disease, and advocates raise awareness and labor to change public policy.  This multi-theater struggle is to end suffering from the most common form of cancer in men according to the CDC.

Continue Reading